🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

State Street SPDR S&P Biotech ETF

XBI
$128.55 +$0.823 (0.64%)
Market Cap: $7.23 B
Gurus Holding
4
Popularity Rank
#2599
% of Shares Held
3.42%
Net Activity (Q4 2025)
+$27.81 M

Guru Ownership Trend

Guru Analysis for State Street SPDR S&P Biotech ETF (XBI)

State Street SPDR S&P Biotech ETF (XBI), a key player in the Market sector, continues to attract institutional attention.

As of Q4 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $256.01 M.

Top institutional holders include Jefferies Group and Louis Moore Bacon.

Institutional sentiment is currently Bullish. This is evidenced by a $27.81 M net inflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who opened a new position. Conversely, Louis Moore Bacon reduced exposure by 10.0%.

Key Holders

Recent Activity Breakdown (Q4 2025)

+$30.85 M
Total Buy Value
New Buys 1
Additions 2
-$3.05 M
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
1
Net Buyers
3

FAQs for State Street SPDR S&P Biotech ETF (XBI)

Major holders include Jefferies Group ($209.12 M), Louis Moore Bacon ($27.43 M), Renaissance Technologies (RenTech) ($5.01 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 1.99 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $27.81 M, with 3 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited XBI. The total reported sell value was $3.05 M.

Yes, 1 managers opened new positions in XBI, and 2 increased their existing holdings. The total reported buy value was $30.85 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
1.07% Add 13.9% 1,715,089 $209.12 M Q4 2025
0.39% Reduce -10.0% 225,000 $27.43 M Q4 2025
0.01% New Buy 41,100 $5.01 M Q4 2025
0.00% Add 39.6% 10,314 $1.26 M Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form